Multidrug-Resistant Bacterial Colonization and Infections in Large Retrospective Cohort of Mechanically Ventilated COVID-19 Patients
COVID-19
MDR
MDRO
SARS-CoV-2
antimicrobial resistance
antimicrobial stewardship
bacteria
colonization
incidence rate
infections
intensive care unit
large retrospective cohort
mechanically ventilated patients
multidrug resistant
multidrug-resistant bacteria
multidrug-resistant organism
respiratory infections
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
medline:
25
7
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
ppublish
Résumé
Few data are available on incidence of multidrug-resistant organism (MDRO) colonization and infections in mechanically ventilated patients, particularly during the COVID-19 pandemic. We retrospectively evaluated all patients admitted to the COVID-19 intensive care unit (ICU) of Hub Hospital in Milan, Italy, during October 2020‒May 2021. Microbiologic surveillance was standardized with active screening at admission and weekly during ICU stay. Of 435 patients, 88 (20.2%) had MDROs isolated ≤48 h after admission. Of the remaining patients, MDRO colonization was diagnosed in 173 (51.2%), MDRO infections in 95 (28.1%), and non-MDRO infections in 212 (62.7%). Non-MDRO infections occurred earlier than MDRO infections (6 days vs. 10 days; p<0.001). Previous exposure to antimicrobial drugs within the ICU was higher in MDRO patients than in non-MDRO patients (116/197 [58.9%] vs. 18/140 [12.9%]; p<0.001). Our findings might serve as warnings for future respiratory viral pandemics and call for increased measures of antimicrobial stewardship and infection control.
Identifiants
pubmed: 37486196
doi: 10.3201/eid2908.230115
pmc: PMC10370845
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1598-1607Références
Microb Drug Resist. 2018 Mar;24(2):190-198
pubmed: 28749714
Intensive Care Med. 2023 Feb;49(2):178-190
pubmed: 36764959
Clin Microbiol Infect. 2020 Jan;26(1):87-94
pubmed: 31128285
Chest. 2021 Aug;160(2):454-465
pubmed: 33857475
Lung India. 2022 Mar-Apr;39(2):139-144
pubmed: 35259796
J Infect Dev Ctries. 2022 Aug 30;16(8):1294-1301
pubmed: 36099372
Crit Care. 2022 Jun 13;26(1):176
pubmed: 35698155
Crit Care Med. 2021 Jan 1;49(1):e31-e40
pubmed: 33122577
Intensive Care Med. 2012 Dec;38(12):1930-45
pubmed: 23011531
Microb Drug Resist. 2021 Sep;27(9):1167-1175
pubmed: 33600262
Med Intensiva (Engl Ed). 2021 Jun-Jul;45(5):313-315
pubmed: 34059221
Antibiotics (Basel). 2021 Sep 06;10(9):
pubmed: 34572662
Infect Control Hosp Epidemiol. 2022 Apr;43(4):461-466
pubmed: 33858547
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Microorganisms. 2021 Aug 20;9(8):
pubmed: 34442852
Pharmacotherapy. 2019 Mar;39(3):253-260
pubmed: 30101412
BMC Infect Dis. 2021 Sep 8;21(1):933
pubmed: 34496787
Enferm Infecc Microbiol Clin. 2023 May;41(5):278-283
pubmed: 34908639
JAC Antimicrob Resist. 2022 Jun 16;4(3):dlac064
pubmed: 35719203
BMJ. 1996 Feb 10;312(7027):364-7
pubmed: 8611837
Crit Care Res Pract. 2022 Sep 2;2022:9730895
pubmed: 36092685
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Microorganisms. 2020 Nov 19;8(11):
pubmed: 33227956
Clin Microbiol Infect. 2023 Apr;29(4):530-536
pubmed: 36441042
Lancet Microbe. 2021 Aug;2(8):e354-e365
pubmed: 34100002
J Hosp Infect. 2021 Apr;110:165-171
pubmed: 33561503
J Infect. 2015 Mar;70(3):213-22
pubmed: 25445887
Antibiotics (Basel). 2022 Aug 03;11(8):
pubmed: 36009922
Clin Microbiol Infect. 2023 Mar;29(3):390.e1-390.e4
pubmed: 36404422
Front Cell Infect Microbiol. 2022 Feb 23;12:784130
pubmed: 35281440
Am J Infect Control. 2022 May;50(5):581-584
pubmed: 35158008
Microbiol Spectr. 2023 Mar 28;:e0020923
pubmed: 36976013
JAC Antimicrob Resist. 2022 Dec 29;5(1):dlac130
pubmed: 36601548